Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Providing a Science Base for the Evaluation of Tobacco Products.

Berman ML, Connolly G, Cummings KM, Djordjevic MV, Hatsukami DK, Henningfield JE, Myers M, O'Connor RJ, Parascandola M, Rees V, Rice JM, Shields PG.

Tob Regul Sci. 2015 Apr;1(1):76-93.

2.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.

3.

Non-cigarette tobacco use among women and adverse pregnancy outcomes.

England LJ, Kim SY, Tomar SL, Ray CS, Gupta PC, Eissenberg T, Cnattingius S, Bernert JT, Tita AT, Winn DM, Djordjevic MV, Lambe M, Stamilio D, Chipato T, Tolosa JE.

Acta Obstet Gynecol Scand. 2010;89(4):454-64. doi: 10.3109/00016341003605719. Review.

4.

Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.

Pauly JL, O'Connor RJ, Paszkiewicz GM, Cummings KM, Djordjevic MV, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3321-33. doi: 10.1158/1055-9965.EPI-09-0925. Review.

5.

Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Marian C, O'Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3305-20. doi: 10.1158/1055-9965.EPI-09-1014. Review.

6.

Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3263-304. doi: 10.1158/1055-9965.EPI-09-0965. Review.

7.

Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.

Watanabe KH, Djordjevic MV, Stellman SD, Toccalino PL, Austin DF, Pankow JF.

Regul Toxicol Pharmacol. 2009 Nov;55(2):123-33. doi: 10.1016/j.yrtph.2009.06.007. Epub 2009 Jun 18.

8.

Nicotine content and delivery across tobacco products.

Djordjevic MV, Doran KA.

Handb Exp Pharmacol. 2009;(192):61-82. doi: 10.1007/978-3-540-69248-5_3. Review.

PMID:
19184646
9.

Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products.

Stellman SD, Djordjevic MV.

Prev Med. 2009 Jan;48(1 Suppl):S11-5. doi: 10.1016/j.ypmed.2008.09.004. Epub 2008 Sep 20. Review.

10.

Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.

Melikian AA, Djordjevic MV, Chen S, Richie J Jr, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1408-15.

11.

Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.

Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, Muscat J, Stellman SD.

Nicotine Tob Res. 2007 Mar;9(3):377-87.

PMID:
17365769
12.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

13.

Menthol cigarettes: research needs and challenges.

Henningfield JE, Djordjevic MV.

Nicotine Tob Res. 2004 Feb;6 Suppl 1:S11-6. No abstract available.

PMID:
14982705
14.

Menthol cigarettes: setting the research agenda.

Clark PI, Gardiner PS, Djordjevic MV, Leischow SJ, Robinson RG.

Nicotine Tob Res. 2004 Feb;6 Suppl 1:S5-9. No abstract available.

PMID:
14982704
15.

Smoking reduction and tobacco-related cancers: the more things change, the more they stay the same.

Leischow SJ, Djordjevic MV.

J Natl Cancer Inst. 2004 Jan 21;96(2):86-7. No abstract available.

PMID:
14734690
16.

Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York.

Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1474-8.

17.

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.

Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF.

Nicotine Tob Res. 2003 Dec;5(6):891-9.

PMID:
14668073
18.

Lung cancer risk in white and black Americans.

Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, Thompson S, Altorki N, Berwick M, Citron ML, Harlap S, Kaur TB, Neugut AI, Olson S, Travaline JM, Witorsch P, Zhang ZF.

Ann Epidemiol. 2003 Apr;13(4):294-302.

PMID:
12684197
19.

Smoking and lung cancer risk in American and Japanese men: an international case-control study.

Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV, Harlap S, Muscat JE, Neugut AI, Wynder EL, Ogawa H, Tajima K, Aoki K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1193-9.

20.

Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Hurt RD, Croghan GA, Wolter TD, Croghan IT, Offord KP, Williams GM, Djordjevic MV, Richie JP Jr, Jeffrey AM.

Nicotine Tob Res. 2000 Nov;2(4):327-36.

PMID:
11197312
21.

Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York.

Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1241-9.

22.

Doses of nicotine and lung carcinogens delivered to cigarette smokers.

Djordjevic MV, Stellman SD, Zang E.

J Natl Cancer Inst. 2000 Jan 19;92(2):106-11.

PMID:
10639511
23.

Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York.

Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E, Nafziger AN.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):489-96.

24.

Chemical composition and carcinogenicity of smokeless tobacco.

Hoffmann D, Djordjevic MV.

Adv Dent Res. 1997 Sep;11(3):322-9. Review.

PMID:
9524432
25.

Nicotine regulates smoking patterns.

Djordjevic MV, Hoffmann D, Hoffmann I.

Prev Med. 1997 Jul-Aug;26(4):435-40.

PMID:
9245662
26.

The changing cigarette.

Hoffmann D, Djordjevic MV, Hoffmann I.

Prev Med. 1997 Jul-Aug;26(4):427-34. Review.

PMID:
9245661
27.

Formation and analysis of tobacco-specific N-nitrosamines.

Brunnemann KD, Prokopczyk B, Djordjevic MV, Hoffmann D.

Crit Rev Toxicol. 1996;26(2):121-37. Review.

PMID:
8688156
28.

Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.

Hoffmann D, Djordjevic MV, Fan J, Zang E, Glynn T, Connolly GN.

J Natl Cancer Inst. 1995 Dec 20;87(24):1862-9.

PMID:
7494230
29.
30.

Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes.

Djordjevic MV, Fan J, Ferguson S, Hoffmann D.

Carcinogenesis. 1995 Sep;16(9):2015-21.

PMID:
7554048
31.

Assessment of chlorinated pesticides and polychlorinated biphenyls in adipose breast tissue using a supercritical fluid extraction method.

Djordjevic MV, Hoffmann D, Fan J, Prokopczyk B, Citron ML, Stellman SD.

Carcinogenesis. 1994 Nov;15(11):2581-5.

PMID:
7955109
32.

Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.

Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV.

J Toxicol Environ Health. 1994 Jan;41(1):1-52. Review.

PMID:
8277523
33.

A study of tobacco carcinogenesis. LI. Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumours in A/J mice.

Hoffmann D, Djordjevic MV, Rivenson A, Zang E, Desai D, Amin S.

Cancer Lett. 1993 Jul 30;71(1-3):25-30.

PMID:
8364894
34.

The need for regulation of carcinogenic N-nitrosamines in oral snuff.

Djordjevic MV, Brunnemann KD, Hoffmann D.

Food Chem Toxicol. 1993 Jul;31(7):497-501.

PMID:
8340028
35.

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

Williams GM, Iatropoulos MJ, Djordjevic MV, Kaltenberg OP.

Carcinogenesis. 1993 Feb;14(2):315-7.

PMID:
8435874
36.

Supercritical fluid extraction in the determination of tobacco-specific N-nitrosamines in smokeless tobacco.

Prokopczyk B, Hoffmann D, Cox JE, Djordjevic MV, Brunnemann KD.

Chem Res Toxicol. 1992 May-Jun;5(3):336-40.

PMID:
1504255
37.

Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR cigarettes.

Djordjevic MV, Sigountos CW, Hoffmann D, Brunnemann KD, Kagan MR, Bush LP, Safaev RD, Belitsky GA, Zaridze D.

Int J Cancer. 1991 Feb 1;47(3):348-51.

PMID:
1993541
38.

New brands of oral snuff.

Hoffmann D, Djordjevic MV, Brunnemann KD.

Food Chem Toxicol. 1991 Jan;29(1):65-8.

PMID:
1999307
39.

Analysis and pyrolysis of some N-nitrosamino acids in tobacco and tobacco smoke.

Brunnemann KD, Djordjevic MV, Feng R, Hoffmann D.

IARC Sci Publ. 1991;(105):477-81.

PMID:
1855899
40.

A study of tobacco carcinogenesis XLIV. Bioassay in A/J mice of some N-nitrosamines.

Rivenson A, Djordjevic MV, Amin S, Hoffmann R.

Cancer Lett. 1989 Sep 15;47(1-2):111-4.

PMID:
2636026
41.

Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco.

Djordjevic MV, Brunnemann KD, Hoffmann D.

Carcinogenesis. 1989 Sep;10(9):1725-31.

PMID:
2766465

Supplemental Content

Loading ...
Support Center